John Mervyn Carter

Title: John Mervyn Carter: Innovator in Neoplastic Disease Treatment

Introduction

John Mervyn Carter is a notable inventor based in Southampton, GB. He has made significant contributions to the field of medical treatments, particularly in the area of neoplastic diseases. With a total of 6 patents to his name, Carter's work has the potential to impact the lives of many patients.

Latest Patents

Carter's latest patents include a method of treating neoplastic disease in a human or animal patient. This method involves administering an anti-neoplastic effective amount of a composition that includes copper gluconate or copper orotate, sodium salicylate, vitamin C, manganese gluconate or manganese orotate, and optionally one or more of iron gluconate or iron orotate, sublimed sulphur, and zinc gluconate or zinc orotate. Additionally, he has developed pharmaceutical compositions that consist of a physiologically acceptable source of assimilable copper, a source of salicylic acid or a physiologically acceptable derivative thereof, and vitamin C.

Career Highlights

Throughout his career, John Mervyn Carter has worked with prominent organizations, including the International Business Machines Corporation (IBM). His innovative approaches to treatment have garnered attention in the medical community.

Collaborations

Carter has collaborated with various professionals in his field, including his coworker, Edmund James Whittaker West. Their combined expertise has contributed to the advancement of medical treatments.

Conclusion

John Mervyn Carter's contributions to the treatment of neoplastic diseases through his innovative patents highlight his role as a significant figure in medical research. His work continues to pave the way for new therapeutic approaches that may benefit countless patients in the future.